| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.47 | 2e-16 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.4 | 4e-11 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.1 |